SCHEMBL8271360

SCHEMBL8271360

CCOC(=O)Cn1c(=O)n(Cc2ccc3cccnc3n2)c(=O)c2c1nc(N1CCCC(N)C1)n2CC

nearest known ligand 0.51

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 18/20 0.51
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ CHRM1 P11229 6/20 0.45
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CHRM2 P08172 1/20 0.43
▸ CHRM3 P20309 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13923864 0.92 DPP4 (0.59) DPP4CHRM1CHRM3
SCHEMBL13944303 0.86 ALDH1A1 (0.49) DPP4ALDH1A1LMNATSHRNPSR1
SCHEMBL8271365 0.86 DPP4 (0.63) DPP4CHRM1
SCHEMBL13945311 0.85 DPP4 (0.54) DPP4ALDH1A1LMNATSHRNPSR1
SCHEMBL8270402 0.85 DPP4 (0.53) DPP4ALDH1A1LMNATSHRNPSR1
SCHEMBL13944715 0.85 DPP4 (0.49) DPP4ALDH1A1LMNATSHRNPSR1
SCHEMBL13944753 0.84 ALDH1A1 (0.49) DPP4ALDH1A1LMNATSHRNPSR1
SCHEMBL13946040 0.84 DPP4 (0.49) DPP4ALDH1A1LMNATSHRNPSR1
SCHEMBL13946039 0.84 DPP4 (0.47) DPP4ALDH1A1LMNATSHRNPSR1
SCHEMBL8271389 0.83 DPP4 (0.58) DPP4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495003-B2 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 — — US disclosed
WO-2006027204-A1 8-(3-AMINO-PIPERIDIN-1-YL)-7-(BUT-2-INYL)-XANTHINES, PRODUCTION THEREOF AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-16 — — WO disclosed
Send feedback